Cite

HARVARD Citation

    Aravena, O. et al. (2017). TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis research & therapy. 19 (1), pp. 1-13. [Online]. 
  
Back to record